|
JPS58500526A
(ja)
*
|
1981-04-17 |
1983-04-07 |
アメリカン ホスピタル サプライ コ−ポレ−シヨン |
非経口栄養供給のための改良溶液
|
|
FR2508797B1
(fr)
*
|
1981-07-03 |
1986-03-14 |
Charles Chany |
Medicament comprenant le produit de la reaction d'un acide carboxylique en c1 a c6 sur un amino-acide basique
|
|
DE3329253A1
(de)
*
|
1983-08-12 |
1985-02-21 |
Milupa Ag, 6382 Friedrichsdorf |
Verwendung eines aminosaeuregemisches zur bekaempfung insbesondere von lymphadenomen
|
|
HU191598B
(en)
*
|
1984-03-20 |
1987-03-30 |
Egyt Gyogyszervegyeszeti Gyar |
Method for the preparation of injection solution suitable preferably against cathosis
|
|
DE3440090A1
(de)
*
|
1984-11-02 |
1986-05-07 |
Novo-Med AG, Appenzell |
Aminosaeureloesungen enthaltendes arzneimittel zur therapie von krebserkrankungen und verfahren zu seiner herstellung
|
|
IL77629A
(en)
*
|
1985-01-22 |
1989-07-31 |
Abbott Lab |
High fat,low carbohydrate enteral nutritional for mula
|
|
FR2591893B1
(fr)
*
|
1985-12-19 |
1988-11-10 |
Centre Nat Rech Scient |
Compositions nutritionnelles carencees en methionine destinees a inhiber le developpement et la dissemination des tumeurs malignes chez les mammiferes
|
|
US5162373A
(en)
*
|
1986-01-17 |
1992-11-10 |
Board Of Regents, The University Of Texas System |
Methods and improved formulations for the determination and treatment of malignant disease in patients
|
|
US5189025A
(en)
*
|
1988-12-09 |
1993-02-23 |
Board Of Regenets, The University Of Texas System |
Methods for the treatment of malignant disease in patients using citrulline containing amino acid solutions
|
|
GB8917660D0
(en)
*
|
1989-08-02 |
1989-09-20 |
Rana Ashok S J |
Prophylaxis of transurethral resection reactions
|
|
US5658895A
(en)
*
|
1991-10-07 |
1997-08-19 |
Otsuka Pharmaceutical Factory, Inc. |
Anticancer enteral feeding composition
|
|
ATE183923T1
(de)
*
|
1991-10-07 |
1999-09-15 |
Otsuka Pharma Co Ltd |
Enterale zubereitungen zur krebstherapie
|
|
DE4228897A1
(de)
*
|
1992-08-29 |
1994-03-03 |
Wella Ag |
Mittel zur Festigung der Haare auf der Basis von Lignin oder Ligninderivaten sowie Dihydroxypropyllignin
|
|
JP2930723B2
(ja)
*
|
1992-11-19 |
1999-08-03 |
アンティキャンサー インコーポレーテド |
抗メチオニン化学療法における抗腫瘍薬としてのメチオニナーゼの使用
|
|
HU213677B
(en)
*
|
1993-11-09 |
1997-12-29 |
Immunal Kft |
Pharmaceutical compositions for preventing and treating tumor diseases, and process for producing them
|
|
RU2125874C1
(ru)
*
|
1994-07-04 |
1999-02-10 |
Казанский государственный университет им.В.И.Ульянова-Ленина |
Композиция аминокислот с микроэлементами, обладающая противоопухолевой и антигипоксической активностью
|
|
EP0921794A1
(en)
*
|
1996-07-30 |
1999-06-16 |
Novartis Nutrition AG |
Amino acid composition and use thereof in treating tumor growth and metastasis
|
|
EP1068868A3
(en)
*
|
1997-07-08 |
2001-01-31 |
Rath, Matthias, Dr. med. |
Synergistic compositions comprising ascorbate and lysine for states related to extracellular matrix degeneration
|
|
RU2144821C1
(ru)
*
|
1999-02-16 |
2000-01-27 |
Товарищество с ограниченной ответственностью Фирма "ГЛЕС" |
Противоопухолевое средство
|
|
ATE323479T1
(de)
*
|
2000-06-16 |
2006-05-15 |
Matthias Dr Med Rath |
Zusammensetzung für die verhinderung der glattmuskelkrankheiten, die ascorbat, arginin und magnesium enthält
|
|
ES2261136T3
(es)
*
|
2000-10-09 |
2006-11-16 |
Matthias Dr. Med. Rath |
Composicion terapeutica de ascorbato con lisina y arginina para prevencion y tratamiento del cancer.
|
|
CH694549A5
(de)
|
2001-01-16 |
2005-03-31 |
Dr Matthias Rath |
Verwendung einer synergistischen Zusammensetzung, die Ascorbat und Lysin für Zustände enthält zur Behandlung extrazellularer Matrixdegeration.
|
|
US6686340B2
(en)
|
2001-06-19 |
2004-02-03 |
Matthias Rath |
Composition and method for prevention and treatment of health conditions caused by constriction of smooth muscle cells
|
|
SG106614A1
(en)
*
|
2001-06-21 |
2004-10-29 |
Matthias Rath Dr |
Use of biochemical substances for a composition for the prevention and treatment of health conditions caused by constriction of smooth muscle cells in organs of the human body
|
|
WO2003030890A1
(fr)
*
|
2001-10-05 |
2003-04-17 |
Tetsuro Asao |
Activateurs du systeme immunitaire
|
|
US20030105104A1
(en)
*
|
2001-11-27 |
2003-06-05 |
Burzynski Stanislaw R. |
Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy
|
|
US20050053664A1
(en)
|
2003-09-08 |
2005-03-10 |
Eliezer Zomer |
Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
|
|
WO2005092097A1
(en)
*
|
2004-03-19 |
2005-10-06 |
Pro-Pharmaceuticals, Inc. |
Compositions and methods for targeting metastatic tumors using multivalent ligand-linked carbohydrate polymers
|
|
PT1909600E
(pt)
|
2005-07-29 |
2012-07-24 |
Tima Foundation |
Composição para moderar o metabolismo do álcool e para reduzir o risco de doenças induzidas pelo álcool
|
|
WO2007016954A1
(en)
*
|
2005-07-29 |
2007-02-15 |
Matuschka-Greiffenclau Markus |
Composition for reducing drug or alcohol induced breast cancer risk
|
|
WO2007016949A1
(en)
*
|
2005-07-29 |
2007-02-15 |
Matuschka-Greiffenclau Markus |
Composition for reducing the risc of alcohol induced neuropathy
|
|
WO2007016950A1
(en)
*
|
2005-07-29 |
2007-02-15 |
Matuschka-Greiffenclau Markus |
Composition for reducing the risk of alcohol induced neurodegenerative disease
|
|
WO2007016955A1
(en)
*
|
2005-07-29 |
2007-02-15 |
Matuschka-Greiffenclau Markus |
Alcohol metabolism moderating composition
|
|
WO2007016951A1
(en)
*
|
2005-07-29 |
2007-02-15 |
Matuschka-Greiffenclau Markus |
Composition for reducing the risc of alcohol induced pancreatic cancer
|
|
WO2007016952A1
(en)
*
|
2005-07-29 |
2007-02-15 |
Matuschka-Greiffenclau Markus |
Composition for reducing the risk of alcohol induced esophagenal and oropharyngolaryngeal cancer
|
|
US8865646B2
(en)
|
2007-03-28 |
2014-10-21 |
University Of South California |
Dietary compositions and methods for protection against chemotherapy, radiotherapy, oxidative stress, and aging
|
|
EP2156188B1
(en)
|
2007-03-28 |
2021-05-05 |
University of Southern California |
Induction of differential stress resistance and uses thereof
|
|
ES2800327T3
(es)
|
2008-04-24 |
2020-12-29 |
Univ Of Southern California Usc Stevens |
Composiciones dietéticas y métodos de protección contra la quimioterapia o radioterapia
|
|
WO2012111790A1
(ja)
*
|
2011-02-17 |
2012-08-23 |
味の素株式会社 |
化学療法剤の抗腫瘍活性増強剤
|
|
JP2016117702A
(ja)
*
|
2014-12-22 |
2016-06-30 |
武輝 山田 |
ガン細胞の死滅法
|
|
JOP20190146A1
(ar)
|
2016-12-19 |
2019-06-18 |
Axcella Health Inc |
تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
|
|
US10682325B2
(en)
|
2017-08-14 |
2020-06-16 |
Axcella Health Inc. |
Compositions and methods for the treatment of liver diseases and disorders associated with one or both of hyperammonemia or muscle wasting
|
|
JP2021527670A
(ja)
|
2018-06-20 |
2021-10-14 |
アクセラ・ヘルス・インコーポレイテッドＡｘｃｅｌｌａ Ｈｅａｌｔｈ Ｉｎｃ． |
筋肉中の脂肪浸潤の治療のための組成物及び方法
|
|
IT201900002109A1
(it)
|
2019-02-13 |
2020-08-13 |
Professional Dietetics Spa |
Composizioni comprendenti amminoacidi per l'uso nel trattamento di lesioni del sistema nervoso centrale
|
|
IT202000000454A1
(it)
*
|
2020-01-13 |
2021-07-13 |
Professional Dietetics Spa |
Composizioni comprendenti amino acidi per la prevenzione e il trattamento del cancro
|
|
IT202000000442A1
(it)
|
2020-01-13 |
2021-07-13 |
Professional Dietetics Spa |
Composizioni comprendenti amino acidi per l'uso nella prevenzione e nel trattamento di effetti collaterali della chemioterapia
|